Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HepNet Acute HCV IV: Ledipasvir/Sofosbuvir for Acute Genotype 1 HCV
NCT02309918Phase 2Completed
- Start
- Nov 2014
- Primary completion
- Aug 2016
- Modality
- Implantable Devices, Transdermal Patches, Inhalation Devices
- Countries
- 1
01
Overview
A Phase 2 trial of Harvoni in hepatitis C virus infection. Started Nov 2014; status: completed.
02
Drugs
Harvoni
03
Conditions
hepatitis C virus infection
Beyond the preview
Go deeper on NCT02309918.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02309918.